Davis Capital Management
ELV icon

Davis Capital Management’s Elevance Health ELV Stock Holding History

Davis Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.33K Sell
6
-41
-87% -$16.4K ﹤0.01% 376
2026
Q2 		$18.2K Buy
47
+4
+9% +$1.48K 0.01% 220
2026
Q1 		$12.6K Hold
43
– – 0.01% 208
2025
Q4 		$15.1K Hold
43
– – 0.01% 206
2025
Q3 		$13.9K Buy
+43
New +$13.4K 0.01% 205
2025
Q1 		$17.8K Hold
41
– – 0.01% 196
2024
Q4 		$15.1K Hold
41
– – 0.01% 200
2024
Q3 		$21.3K Hold
41
– – 0.02% 195
2024
Q2 		$21.9K Hold
41
– – 0.02% 185
2024
Q1 		$21.2K Hold
41
– – 0.02% 181
2023
Q4 		$19.3K Buy
+41
New +$19K 0.02% 183
2020
Q2 		$13K Hold
51
– – 0.02% 176
2020
Q1 		$12K Buy
+51
New +$13.9K 0.03% 175

Other funds holding ELV

Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Davis Capital Management's ELV Position: Q3 2026 in Review

Davis Capital Management reduced its Elevance Health (ELV) stake by 87% in Q3 2026, selling an estimated $16.4K and leaving 6 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Davis Capital Management first reported a position in ELV in Q1 2020 and has held it in 13 quarters since. The position peaked at $21.9K in Q2 2024. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Davis Capital Management held 6 shares of Elevance Health worth $2.33K as of Q3 2026.
  • Davis Capital Management sold 41 Elevance Health shares in Q3 2026, an estimated $16.4K.
  • Elevance Health made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #376 holding.
  • Davis Capital Management first reported a position in Elevance Health in Q1 2020 and has held it in 13 quarters since.
  • Davis Capital Management's Elevance Health position peaked at $21.9K in Q2 2024.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.